Agent Selection for Overactive Bladder Patients With and Without Documented Comorbid Benign Prostatic Hyperplasia
Jumadilova Z1, Harris H2, del Aguila M2, Wagner S1, Boccuzzi S2, Bavendam T1 1. Pfizer, Inc, 2. Aetna Health Information Solutions
|
Abstract 486
|
|
Read By Title
Scientific Non Discussion Abstract Session 19
|
|